For: | Prasad GVR. Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol 2014; 3(4): 210-219 [PMID: 25374814 DOI: 10.5527/wjn.v3.i4.210] |
---|---|
URL: | https://www.wjgnet.com/2220-6124/full/v3/i4/210.htm |
Number | Citing Articles |
1 |
H.-H. Chang, H.-N. Chao, C. S. Walker, S.-Y. Choong, A. Phillips, K. M. Loomes. Renal depletion ofmyo-inositol is associated with its increased degradation in animal models of metabolic disease. American Journal of Physiology-Renal Physiology 2015; 309(9): F755 doi: 10.1152/ajprenal.00164.2015
|
2 |
Ryuichi Kawamoto, Daisuke Ninomiya, Taichi Akase, Asuka Kikuchi, Yoshihisa Kasai, Tomo Kusunoki, Nobuyuki Ohtsuka, Teru Kumagi. Serum Uric Acid to Creatinine Ratio Independently Predicts Incident Metabolic Syndrome Among Community-Dwelling Persons. Metabolic Syndrome and Related Disorders 2019; 17(2): 81 doi: 10.1089/met.2018.0055
|
3 |
Hee-Seong Jang, Mi Ra Noh, Troy Plumb, Kyung Lee, John Cijiang He, Fernando A. Ferrer, Babu J. Padanilam. Hepatic and proximal tubule angiotensinogen play distinct roles in kidney dysfunction, glomerular and tubular injury, and fibrosis progression. American Journal of Physiology-Renal Physiology 2022; 323(4): F435 doi: 10.1152/ajprenal.00029.2022
|
4 |
María E Lizardo, María del Pilar Navarro, Marqjuly Camacho, Melvimar Alejandra Magallanes-Hernández, Rubsy Gabriela Pacheco-Gutiérrez, Mariela López-Bordones, Román Cabello, Gregoria González-Mayo, Hember Vicci, Luis Dorta. Estimación de la tasa de filtración glomerular en personas con y sin síndrome metabólico. Revista Facultad de Ciencias de la Salud UDES 2016; 3(1): 22 doi: 10.20320/rfcsudes.v3i1.102
|
5 |
Shin Yeong Kang, Yu Ho Lee, Su Jin Jeong, Jin Sug Kim, Kyung Hwan Jeong, Hyeon Seok Hwang. How obesity and metabolic syndrome affect cardiovascular events, progression to kidney failure and all-cause mortality in chronic kidney disease. Nephrology Dialysis Transplantation 2024; 39(5): 778 doi: 10.1093/ndt/gfad214
|
6 |
Emanuel Zitt, Constanze Pscheidt, Hans Concin, Reinhard Kramar, Raphael S. Peter, Jan Beyersmann, Karl Lhotta, Gabriele Nagel. Long-term risk for end-stage kidney disease and death in a large population-based cohort. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-26087-z
|
7 |
Kai-Jyun Chang, Jer-An Lin, Sheng-Yi Chen, Ming-Hung Weng, Gow-Chin Yen. Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1. Journal of Functional Foods 2019; 56: 136 doi: 10.1016/j.jff.2019.03.012
|
8 |
Mo-Yao Tan, Yu-Jun Zhang, Si-Xuan Zhu, Shan Wu, Ping Zhang, Ming Gao. The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0–3 of cardiovascular–kidney–metabolic syndrome: evidence from two cohort studies. Cardiovascular Diabetology 2025; 24(1) doi: 10.1186/s12933-025-02689-6
|
9 |
Ming-Shu Chen, Tzu-Chi Liu, Mao-Jhen Jhou, Chih-Te Yang, Chi-Jie Lu. Analyzing Longitudinal Health Screening Data with Feature Ensemble and Machine Learning Techniques: Investigating Diagnostic Risk Factors of Metabolic Syndrome for Chronic Kidney Disease Stages 3a to 3b. Diagnostics 2024; 14(8): 825 doi: 10.3390/diagnostics14080825
|
10 |
Shu-Hong Xu, Nan Qiao, Jian-Jun Huang, Chen-Ming Sun, Yan Cui, Shuang-Shuang Tian, Cong Wang, Xiao-Meng Liu, Hai-Xia Zhang, Hui Wang, Jie Liang, Qing Lu, Tong Wang. Gender Differences in Dietary Patterns and Their Association with the Prevalence of Metabolic Syndrome among Chinese: A Cross-Sectional Study. Nutrients 2016; 8(4): 180 doi: 10.3390/nu8040180
|
11 |
Bárbara Loures Peralva, Kelli Borges dos Santos, Marina Guedes Fraga Lopes, Mario Flávio Cardoso de Lima, Claudio Teodoro de Souza. Effect of clinical treatments for metabolic syndrome on albuminuria: a systematic review protocol. REVISTA CIÊNCIAS EM SAÚDE 2023; 13(1): 22 doi: 10.21876/rcshci.v13i1.1389
|
12 |
Vincent Boima, Alexander B. Agyekum, Augustus K. Eduafo. Metabolic Syndrome. 2023; : 675 doi: 10.1007/978-3-031-40116-9_57
|
13 |
Shwetal Lalan, Shuai Jiang, Derek K. Ng, Fernanda Kupferman, Bradley A. Warady, Susan Furth, Mark M. Mitsnefes. Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children. The Journal of Pediatrics 2018; 202: 163 doi: 10.1016/j.jpeds.2018.06.007
|
14 |
Maximilian J. Ganz, Sascha T. Bender, Christian Gross, Katrin Bose, Peter R. Mertens, Florian G. Scurt. Metabolisches Syndrom und Nierenkrankheiten. Die Nephrologie 2022; 17(5): 291 doi: 10.1007/s11560-022-00595-6
|
15 |
Sheng-Pyng Chen, Chi-Rong Li, Huan-Cheng Chang, Yu-Ling Li, Hsiang-Chu Pai. Relationship Between Metabolic Syndrome Severity and Kidney Function as Related to Gender: A Population-Based Longitudinal Study. Clinical Nursing Research 2020; 29(6): 355 doi: 10.1177/1054773818773385
|
16 |
Soohyeon Koo, Mina Kim, Hyun Min Cho, Inkyeom Kim. Maternal high-fructose intake during pregnancy and lactation induces metabolic syndrome in adult offspring. Nutrition Research and Practice 2021; 15(2): 160 doi: 10.4162/nrp.2021.15.2.160
|
17 |
Bo La Han, Qiunong Guan, Irina Chafeeva, Asher A. Mendelson, Gerald da Roza, Richard Liggins, Jayachandran N. Kizhakkedathu, Caigan Du. Peritoneal and Systemic Responses of Obese TypeIIDiabetic Rats to Chronic Exposure to a Hyperbranched Polyglycerol‐Based Dialysis Solution. Basic & Clinical Pharmacology & Toxicology 2018; 123(4): 494 doi: 10.1111/bcpt.13038
|
18 |
Susara Madduma Hewage, Suvira Prashar, Samir C. Debnath, Karmin O, Yaw L. Siow. Inhibition of Inflammatory Cytokine Expression Prevents High-Fat Diet-Induced Kidney Injury: Role of Lingonberry Supplementation. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00080
|
19 |
Yu Ho Lee, Sang Heon Song, Seung Hwan Song, Ho Sik Shin, Jaeseok Yang, Myoung Soo Kim, Hyeon Seok Hwang, Curie Ahn, Jaeseok Yang, Jin Min Kong, Oh Jung Kwon, Deok Gie Kim, Cheol-Woong Jung, Yeong Hoon Kim, Joong Kyung Kim, Chan-Duck Kim, Ji Won Min, Sung Kwang Park, Yeon Ho Park, Park Jae Berm, Jung Hwan Park, Jong-Won Park, Tae Hyun Ban, Sang Heon Song, Seung Hwan Song, Ho Sik Shin, Chul Woo Yang, Hye Eun Yoon, Kang Wook Lee, Dong Ryeol Lee, Dong Won Lee, Sam Yeol Lee, Sang-Ho Lee, Su Hyung Lee, Jung Jun Lee, Jung Pyo Lee, Jeong-Hoon Lee, Jin Seok Jeon, Heungman Jun, Kyung Hwan Jeong, Ku Yong Chung, Hong Rae Cho, Ju Man Ki, Dong-Wan Chae, Soo Jin Na Choi, Duck Jong Han, Seungyeup Han, Kyu Ha. Clinical implications of changes in metabolic syndrome status after kidney transplantation: a nationwide prospective cohort study. Nephrology Dialysis Transplantation 2023; 38(12): 2743 doi: 10.1093/ndt/gfad115
|
20 |
Hugo Y.‐H. Lin, Li‐Yun Chang, Sheng‐Wen Niu, I‐Ching Kuo, Chia‐Hung Yen, Feng‐Ching Shen, Phang‐Lang Chen, Jer‐Ming Chang, Chi‐Chih Hung. High risk of renal outcome of metabolic syndrome independent of diabetes in patients with CKD stage 1–4: The ICKD database. Diabetes/Metabolism Research and Reviews 2023; 39(4) doi: 10.1002/dmrr.3618
|
21 |
Yajuan Qi, Xiaoqin Guo, Shaodong Guo. Metabolic Syndrome. 2015; : 1 doi: 10.1007/978-3-319-12125-3_28-1
|
22 |
You‐Bin Lee, Kyungdo Han, Bongsung Kim, Ji Eun Jun, Seung‐Eun Lee, Jiyeon Ahn, Gyuri Kim, Sang‐Man Jin, Jae Hyeon Kim. Risk of end‐stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome. Diabetes/Metabolism Research and Reviews 2019; 35(8) doi: 10.1002/dmrr.3197
|
23 |
Abnoos Mokhtari Ardekani, Zahra Hamidi Nava, Burhan Abdullah Zaman, Sahar Vahdat, Amir-Hossein Lame-Jouybari, Azam Mivefroshan. The association between lipid profile, oxidized LDL and the components of metabolic syndrome with serum mineral status and kidney function in individuals with obesity. BMC Research Notes 2023; 16(1) doi: 10.1186/s13104-023-06472-2
|
24 |
Kathleen E. Adair, Kelly R. Ylitalo, Jeffrey S. Forsse, LesLee K. Funderburk, Rodney G. Bowden. Metabolic Constellations, Clusters, and Renal Function: Findings from the 2013–2018 National Health and Nutrition Examination Surveys. Life 2021; 11(9): 904 doi: 10.3390/life11090904
|
25 |
Mao-Jhen Jhou, Ming-Shu Chen, Tian-Shyug Lee, Chih-Te Yang, Yen-Ling Chiu, Chi-Jie Lu. A Hybrid Risk Factor Evaluation Scheme for Metabolic Syndrome and Stage 3 Chronic Kidney Disease Based on Multiple Machine Learning Techniques. Healthcare 2022; 10(12): 2496 doi: 10.3390/healthcare10122496
|
26 |
Marià Alemany. The Metabolic Syndrome, a Human Disease. International Journal of Molecular Sciences 2024; 25(4): 2251 doi: 10.3390/ijms25042251
|
27 |
İhsan Boyacı, Süleyman Yıldırım. Metabolik Sendrom Tedavisinde Bağırsak Mikrobiyotasının Probiyotikler ve Özelinde Saccharomyces Boulardii ile Modülasyonu. Anadolu Kliniği Tıp Bilimleri Dergisi 2017; doi: 10.21673/anadoluklin.260702
|
28 |
Minghui Li, Rong Ji, Zhe Li, Sheng Zhao, Rong Liu, Xi Liu, Yongjian Wu. Impact of metabolic abnormalities on the association between normal-range urinary albumin-to-creatinine ratio and cardiovascular mortality: evidence from the NHANES 1999–2018. Diabetology & Metabolic Syndrome 2024; 16(1) doi: 10.1186/s13098-024-01488-5
|
29 |
Mario Spaggiari, Alessandro Martinino, Giulia Bencini, Mario A. Masrur, Egor Petrochenkov, Amy Lian, Joanna Olazar, Pierpaolo Di Cocco, Jorge Almario-Alvarez, Enrico Benedetti, Ivo Tzvetanov. Timing Considerations for Sleeve Gastrectomy in Kidney Transplant Patients: A Single Center Evaluation. Transplant International 2024; 37 doi: 10.3389/ti.2024.12690
|
30 |
Raphael Enrique G. Tiongco, Engracia S. Arceo, Nicole S. Rivera, Chastene Christopher D. Flake, Archie R. Policarpio. Estimation of salivary glucose, amylase, calcium, and phosphorus among non-diabetics and diabetics: Potential identification of non-invasive diagnostic markers. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2019; 13(4): 2601 doi: 10.1016/j.dsx.2019.07.037
|
31 |
Yun Kyung Cho, Chang Hee Jung. Metabolically Healthy Obesity: Epidemiology, Criteria, and Implications in Chronic Kidney Disease. Journal of Obesity & Metabolic Syndrome 2022; 31(3): 208 doi: 10.7570/jomes22036
|
32 |
Jihyun Yoon, Seok-Jae Heo, Jun-Hyuk Lee, Yu-Jin Kwon, Jung Eun Lee. Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults. Diabetology & Metabolic Syndrome 2023; 15(1) doi: 10.1186/s13098-023-01214-7
|
33 |
Yajuan Qi, Xiaoqin Guo, Shaodong Guo. Metabolic Syndrome. 2016; : 479 doi: 10.1007/978-3-319-11251-0_28
|
34 |
Punnaka Pongpanich, Pasvich Pitakpaiboonkul, Kullaya Takkavatakarn, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Paweena Susantitaphong. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis. International Urology and Nephrology 2018; 50(12): 2261 doi: 10.1007/s11255-018-1991-x
|
35 |
Marzieh Bakhshayeshkaram, Jamshid Roozbeh, Seyed Taghi Heidari, Behnam Honarvar, Mohammad Hossein Dabbaghmanesh, Kamran B. Lankarani. Relationships Between Various Components of Metabolic Syndrome and Chronic Kidney Disease in Shiraz, Iran. International Journal of Endocrinology and Metabolism 2019; 17(2) doi: 10.5812/ijem.81822
|
36 |
Imen Gorsane, Madiha Mahfoudhi, Mounira El Euch, Fathi Younsi, Taieb Ben Abdallah. Is There a Gender Difference of Metabolic Syndrome in Hemodialysis?. International Journal of Clinical Medicine 2015; 6(10): 711 doi: 10.4236/ijcm.2015.610094
|
37 |
Hisham Abusaada, Abeer Elshater. Revisiting Urban Street Planning and Design Factors to Promote Walking as a Physical Activity for Middle-Class Individuals with Metabolic Syndrome in Cairo, Egypt. International Journal of Environmental Research and Public Health 2024; 21(4): 402 doi: 10.3390/ijerph21040402
|
38 |
Amirhosein Ghafouri Asbagh, Mohammadreza Taban Sadeghi, Parisa Ramazanilar, Hooman Nateghian. Worsening renal function in hospitalized patients with systolic heart failure: prevalence and risk factors. ESC Heart Failure 2023; 10(5): 2837 doi: 10.1002/ehf2.14463
|
39 |
Joseph Junior Damba, Katie Bodenstein, Paola Lavin, Jessica Drury, Harmehr Sekhon, Christel Renoux, Emilie Trinh, Soham Rej, Kyle T. Greenway. Psychotropic Drugs and Adverse Kidney Effects: A Systematic Review of the Past Decade of Research. CNS Drugs 2022; 36(10): 1049 doi: 10.1007/s40263-022-00952-y
|
40 |
Wei Li, Anthony J. Kondracki, Ning Sun, Prem Gautam, Mohammad Ebrahimi Kalan, Rime Jebai, Semiu O. Gbadamosi, Wenjie Sun. Nighttime sleep duration, daytime napping, and metabolic syndrome: findings from the China Health and Retirement Longitudinal Study. Sleep and Breathing 2022; 26(3): 1427 doi: 10.1007/s11325-021-02487-w
|
41 |
Shan Yang, Jiaxiu Ling, Siliang Zhang, Yang Li, Gangyi Yang. Metabolic dysfunction, rather than obesity, is a risk factor for chronic kidney disease in Chinese population. The Aging Male 2024; 27(1) doi: 10.1080/13685538.2024.2335158
|
42 |
Ruben Rodriguez, Andrew Lee, Keisa W. Mathis, Hanna J. Broome, Max Thorwald, Bridget Martinez, Daisuke Nakano, Akira Nishiyama, Michael J. Ryan, Rudy M. Ortiz. Angiotensin receptor and tumor necrosis factor-α activation contributes to glucose intolerance independent of systolic blood pressure in obese rats. American Journal of Physiology-Renal Physiology 2018; 315(4): F1081 doi: 10.1152/ajprenal.00156.2018
|
43 |
Lorenz M. Pammer, Claudia Lamina, Ulla T. Schultheiss, Fruzsina Kotsis, Barbara Kollerits, Helena Stockmann, Jan Lipovsek, Heike Meiselbach, Martin Busch, Kai‐Uwe Eckardt, Florian Kronenberg. Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort. Journal of Internal Medicine 2021; 290(6): 1219 doi: 10.1111/joim.13355
|
44 |
Won Jin Cho, Jung-Soo Pyo. Immunohistochemical analysis of the impact of ischemic change in benign prostatic hyperplasia. Pathology - Research and Practice 2020; 216(1): 152694 doi: 10.1016/j.prp.2019.152694
|
45 |
Peng-Lin Tseng, Tung-Ling Chung, Chao-Hsien Lee. Association of Metabolic Syndrome and Other Factors with the Presence of Diabetic Nephropathy in Type 2 Diabetic Patients. International Journal of Environmental Research and Public Health 2023; 20(3): 2453 doi: 10.3390/ijerph20032453
|
46 |
Vincent Boima, Alexander B. Agyekum, Augustus K. Eduafo. Metabolic Syndrome. 2023; : 1 doi: 10.1007/978-3-319-12125-3_57-1
|
47 |
Abdelhalim Boukaba, Fabian Sanchis-Gomar, José Luis García-Giménez. Epigenetic Biomarkers and Diagnostics. 2016; : 37 doi: 10.1016/B978-0-12-801899-6.00003-6
|
48 |
Ana Andres-Hernando, Miguel A. Lanaspa, Masanari Kuwabara, David J. Orlicky, Christina Cicerchi, Elise Bales, Gabriela E. Garcia, Carlos A. Roncal-Jimenez, Yuka Sato, Richard J. Johnson. Obesity causes renal mitochondrial dysfunction and energy imbalance and accelerates chronic kidney disease in mice. American Journal of Physiology-Renal Physiology 2019; 317(4): F941 doi: 10.1152/ajprenal.00203.2019
|
49 |
Chi Chiu Mok. Metabolic syndrome and systemic lupus erythematosus: the connection. Expert Review of Clinical Immunology 2019; 15(7): 765 doi: 10.1080/1744666X.2019.1620601
|
50 |
Ciwan Wang, Chang Liu, Wenqian Xu, Yuliang Cheng, Yahui Guo, Yong Zhao, Fanglin Shen, He Qian. Torularhodin bilosomes attenuate high-fat diet-induced chronic kidney disease in mice by regulating the TLR4/NF-κB pathway. Food Bioscience 2023; 51: 102288 doi: 10.1016/j.fbio.2022.102288
|
51 |
Harry G. Preuss, Gilbert R. Kaats, Nate Mrvichin, Okezie I. Aruoma, Debasis Bagchi, Richard P. Scheckenbach. Exploring the Potential to Extend Productive Lifespan in Nondiabetics through Maintaining Optimal Insulin Sensitivity: Amelioration of an Abated Version of the Metabolic Syndrome. Global Journal of Medical, Pharmaceutical, and Biomedical Update 2024; 19: 1 doi: 10.25259/GJMPBU_83_2023
|
52 |
Manuel Alejandro Vargas-Vargas, Marcela González-Montoya, Olin Torres-Isidro, Claudia Isabel García-Berumen, Omar Ortiz-Avila, Elizabeth Calderón-Cortés, Christian Cortés-Rojo. Assessing the impact of concurrent high-fructose and high-saturated fat diets on pediatric metabolic syndrome: A review. World Journal of Clinical Pediatrics 2024; 13(2): 91478 doi: 10.5409/wjcp.v13.i2.91478
|
53 |
Christopher D. Byrne, Giovanni Targher. NAFLD as a driver of chronic kidney disease. Journal of Hepatology 2020; 72(4): 785 doi: 10.1016/j.jhep.2020.01.013
|
54 |
Basma Eid, Thikryat Neamatallah, Abeer Hanafy, Hany El-Bassossy, Lenah Binmahfouz, Hibah Aldawsari, Atif Hasan, Gamal Abd El-Aziz, Kiran Vemuri, Alexandros Makriyannis. Interference with TGFβ1-Mediated Inflammation and Fibrosis Underlies Reno-Protective Effects of the CB1 Receptor Neutral Antagonists AM6545 and AM4113 in a Rat Model of Metabolic Syndrome. Molecules 2021; 26(4): 866 doi: 10.3390/molecules26040866
|
55 |
Elena Rampanelli, Peter Ochodnicky, Johannes PC Vissers, Loes M Butter, Nike Claessen, Alessia Calcagni, Lotte Kors, Lee A Gethings, Stephan JL Bakker, Martin H de Borst, Gerjan J Navis, Gerhard Liebisch, Dave Speijer, Marius A van den Bergh Weerman, Bettina Jung, Jan Aten, Eric Steenbergen, Gerd Schmitz, Andrea Ballabio, Sandrine Florquin, Johannes MFG Aerts, Jaklien C Leemans. Excessive dietary lipid intake provokes an acquired form of lysosomal lipid storage disease in the kidney. The Journal of Pathology 2018; 246(4): 470 doi: 10.1002/path.5150
|
56 |
Amrit Pal Singh, Tajpreet Kaur, Harpal Singh Buttar. Biochemistry of Cardiovascular Dysfunction in Obesity. 2020; : 111 doi: 10.1007/978-3-030-47336-5_6
|
57 |
Samira Arbabi Jam, Behrooz Moloudpour, Farid Najafi, Mitra Darbandi, Yahya Pasdar. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study. BMC Nephrology 2022; 23(1) doi: 10.1186/s12882-022-02858-9
|
58 |
Monique Marques da Silva, Moisés Felipe Pereira Gomes, Elizabeth de Orleans Carvalho de Moura, Mariana Matera Veras, Melina Chiemi Kubota, Ana Paula Takano, Ana Carolina Cardoso dos Santos, Carolina Gonçalves dos Reis José, Graziele Aparecida da Silva Souza, Naiara Magalhães Cardoso, Debora Estadella, Rafael Herling Lambertucci, Alessandra Medeiros, Jaap A. Joles. Aerobic exercise training combined or not with okra consumption as a strategy to prevent kidney changes caused by metabolic syndrome in Zucker rats. PLOS ONE 2022; 17(6): e0269418 doi: 10.1371/journal.pone.0269418
|
59 |
Anja Bernhardt, Anna Krause, Charlotte Reichardt, Hannes Steffen, Berend Isermann, Uwe Völker, Elke Hammer, Robert Geffers, Lars Philipsen, Kristin Dhjamandi, Sohail Ahmad, Sabine Brandt, Jonathan A. Lindquist, Peter R. Mertens. Excessive sodium chloride ingestion promotes inflammation and kidney fibrosis in aging mice. American Journal of Physiology-Cell Physiology 2023; 325(2): C456 doi: 10.1152/ajpcell.00230.2023
|
60 |
Martina Luetić, Genia Kretzschmar, Maximilian Grobe, Leo Jerčić, Ivana Bota, Vedrana Ivić, Marta Balog, Milorad Zjalić, Marija Vitlov Uljević, Marija Heffer, Robert Gaspar, Tamas Tabi, Katarina Vukojević, Sandor G. Vari, Natalija Filipović. Sex-specific effects of metformin and liraglutide on renal pathology and expression of connexin 45 and pannexin 1 following long-term high-fat high-sugar diet. Acta Histochemica 2021; 123(8): 151817 doi: 10.1016/j.acthis.2021.151817
|
61 |
Katiana Simões Kittelson, Arquimedes Gasparotto Junior, Natasha Fillmore, Roberto da Silva Gomes. Cardiovascular-kidney-metabolic syndrome – An integrative review. Progress in Cardiovascular Diseases 2024; 87: 26 doi: 10.1016/j.pcad.2024.10.012
|
62 |
The prevalence and associated factors of metabolic syndrome among patients with end-stage renal failure undergoing hemodialysis in Indonesia. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2020; 14(6): 2069 doi: 10.1016/j.dsx.2020.10.019
|
63 |
Mona Alshahrani, Laila Zawan Almalki, Noura Abdullah Hasoosah, Alhanouf Hussein Alahmari, Alya Musfer Alqahtani, Amjad Ali Alqahtani, Afrah Mohammed AL Muarfaj, Lamia Saeed Al Ghaseb, Faten Saad Alkahtani, Raghd Yahya Alsharif. Prevalence and assessment of risk factors of chronic kidney disease in the ASIR region of Saudi Arabia. Annals of Medicine & Surgery 2024; 86(7): 3909 doi: 10.1097/MS9.0000000000001755
|
64 |
Nehal S. Wahba, Rasha H. Abdel‐Ghany, Salah A. Ghareib, Mohamed Abdel‐Aal, Amira E. Alsemeh, Dina Sabry. Vitamin D3 potentiates the nephroprotective effects of vildagliptin–metformin combination in a rat model of metabolic syndrome. Fundamental & Clinical Pharmacology 2022; 36(2): 306 doi: 10.1111/fcp.12721
|
65 |
Zhe Shen, Stefan Munker, Fugang Luo, Han Ma, Chaohui Yu, Youming Li, Silvia C. Sookoian. Effect of Non-Alcoholic Fatty Liver Disease on Estimated Glomerular Filtration Rate Could Be Dependent on Age. PLOS ONE 2015; 10(6): e0130614 doi: 10.1371/journal.pone.0130614
|
66 |
Christos Varounis, Loukianos S. Rallidis, Oscar H. Franco, John Lekakis. Prevalence of metabolic syndrome and association with burden of atherosclerotic disease in patients with stable coronary artery disease. Current Medical Research and Opinion 2016; 32(6): 1175 doi: 10.1185/03007995.2016.1163257
|
67 |
Yun Kyung Cho, Jiwoo Lee, Hwi Seung Kim, Joong-Yeol Park, Woo Je Lee, Ye-Jee Kim, Chang Hee Jung. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study. The Journal of Clinical Endocrinology & Metabolism 2020; 105(3): e148 doi: 10.1210/clinem/dgaa033
|
68 |
Seok Hui Kang, Da Jung Jung, Eun Woo Choi, Kyu Hyang Cho, Jong Won Park, Jun Young Do, Sheng-Nan Lu. HbA1c Levels Are Associated with Chronic Kidney Disease in a Non-Diabetic Adult Population: A Nationwide Survey (KNHANES 2011–2013). PLOS ONE 2015; 10(12): e0145827 doi: 10.1371/journal.pone.0145827
|
69 |
Rownock Afruza, Md Akheruzzaman, Nikhil V. Dhurandhar, Vijay Hegde. E4orf1, an Adeno-viral protein, attenuates renal lipid accumulation in high fat fed mice: A novel approach to reduce a key risk factor for chronic kidney disease. Heliyon 2020; 6(10): e05261 doi: 10.1016/j.heliyon.2020.e05261
|
70 |
Florian G. Scurt, Maximilian J. Ganz, Carolin Herzog, Katrin Bose, Peter R. Mertens, Christos Chatzikyrkou. Association of metabolic syndrome and chronic kidney disease. Obesity Reviews 2024; 25(1) doi: 10.1111/obr.13649
|
71 |
Rodrigo López-Baltanás, María E. Rodríguez-Ortiz, Juan M. Díaz-Tocados, Julio M. Martinez-Moreno, Cristina Membrives, Cristian Rodelo-Haad, M. Victoria Pendón Ruiz de Mier, Mariano Rodríguez, Antonio Canalejo, Yolanda Almadén, Juan R. Muñoz-Castañeda. Dietary Mg Supplementation Decreases Oxidative Stress, Inflammation, and Vascular Dysfunction in an Experimental Model of Metabolic Syndrome with Renal Failure. Antioxidants 2023; 12(2): 283 doi: 10.3390/antiox12020283
|
72 |
Tianyuan Yang, Bingqing Yang, Jingya Yin, Chenxue Hou, Qi Wang. Targeting Insulin Resistance and Liver Fibrosis: CKD Screening Priorities in MASLD. Biomedicines 2025; 13(4): 842 doi: 10.3390/biomedicines13040842
|
73 |
Danielle Camer, Yinghua Yu, Alexander Szabo, Hongqin Wang, Chi H.L. Dinh, Xu-Feng Huang. Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet. Chemico-Biological Interactions 2016; 243: 10 doi: 10.1016/j.cbi.2015.11.018
|
74 |
Gyongyi Szabo, Timea Csak. Role of MicroRNAs in NAFLD/NASH. Digestive Diseases and Sciences 2016; 61(5): 1314 doi: 10.1007/s10620-015-4002-4
|
75 |
Ying-Ju Ou, Jia-In Lee, Shu-Pin Huang, Szu-Chia Chen, Jiun-Hung Geng, Chia-Hung Su. Association between Menopause, Postmenopausal Hormone Therapy and Metabolic Syndrome. Journal of Clinical Medicine 2023; 12(13): 4435 doi: 10.3390/jcm12134435
|
76 |
Francesco Giangregorio, Emilio Mosconi, Maria Grazia Debellis, Stella Provini, Ciro Esposito, Matteo Garolfi, Simona Oraka, Olga Kaloudi, Gunel Mustafazade, Raquel Marín-Baselga, Yale Tung-Chen. A Systematic Review of Metabolic Syndrome: Key Correlated Pathologies and Non-Invasive Diagnostic Approaches. Journal of Clinical Medicine 2024; 13(19): 5880 doi: 10.3390/jcm13195880
|
77 |
Sahar Youssef Al-Okbi, Salem Abd El Ghani, Hagar Elbakry, Hoda Mabrok, Soad Nasr, Hassan Desouky, Khaled Mahmoud. Kishk Sa′eedi as a potential functional food for management of metabolic syndrome: A study of the possible interaction with pomegranate seed oil and/ or gum Arabic. Journal of Herbmed Pharmacology 2021; 10(3): 319 doi: 10.34172/jhp.2021.37
|
78 |
Hoda E. Mohamed, Merna A. Abdelhady, Asmaa M. Elmaghraby, Rania A. Elrashidy. Empagliflozin and pirfenidone confer renoprotection through suppression of glycogen synthase kinase-3β and promotion of tubular regeneration in rats with induced metabolic syndrome. Toxicology and Applied Pharmacology 2024; 485: 116892 doi: 10.1016/j.taap.2024.116892
|
79 |
Ramy M Hanna, Antoney Ferrey, Connie M Rhee, Kamyar Kalantar-Zadeh. Renal-Cerebral Pathophysiology: The Interplay Between Chronic Kidney Disease and Cerebrovascular Disease. Journal of Stroke and Cerebrovascular Diseases 2021; 30(9): 105461 doi: 10.1016/j.jstrokecerebrovasdis.2020.105461
|
80 |
Seung Hyun Han, Seung Ku Lee, Chol Shin, Sang Youb Han. The eGFR Decline as a Risk Factor for Metabolic Syndrome in the Korean General Population: A Longitudinal Study of Individuals with Normal or Mildly Reduced Kidney Function. Biomedicines 2023; 11(4): 1102 doi: 10.3390/biomedicines11041102
|
81 |
Haneen Yahia, Azza Hassan, Mona R. El-Ansary, Muhammad Y. Al-Shorbagy, Mohamed F. El-Yamany. IL-6/STAT3 and adipokine modulation using tocilizumab in rats with fructose-induced metabolic syndrome. Naunyn-Schmiedeberg's Archives of Pharmacology 2020; 393(12): 2279 doi: 10.1007/s00210-020-01940-z
|
82 |
Trujillo Joyce, Yolanda Irasema Chirino, Martínez-Tagüeña Natalia, Pedraza-Chaverri Jose. Renal damage in the metabolic syndrome (MetSx): Disorders implicated. European Journal of Pharmacology 2018; 818: 554 doi: 10.1016/j.ejphar.2017.11.032
|
83 |
Priscila Calle, Selene Torrico, Angeles Muñoz, Georgina Hotter. CPT1a downregulation protects against cholesterol-induced fibrosis in tubular epithelial cells by downregulating TGFβ-1 and inflammasome. Biochemical and Biophysical Research Communications 2019; 517(4): 715 doi: 10.1016/j.bbrc.2019.07.121
|
84 |
Angélica Ruiz-Ramírez, Miguel Barrios-Maya, Hector Quezada-Pablo, Ocarol López-Acosta, Mohammed El-Hafidi. Kidney dysfunction induced by a sucrose-rich diet in rat involves mitochondria ROS generation, cardiolipin changes, and the decline of autophagy protein markers. American Journal of Physiology-Renal Physiology 2020; 318(1): F53 doi: 10.1152/ajprenal.00208.2019
|
85 |
Rafael Valdez Ortiz, Samantha Escorza-Valdivia, Sigfrido Benitez-Renteria, Juan Carlos Lopez-Alvarenga, L. Monserrat Pérez-Navarro. Factors of Poor Prognosis Associated with Chronic Kidney Disease by Stage in Ambulatory Patients: A Cross-sectional Study. Archives of Medical Research 2022; 53(5): 524 doi: 10.1016/j.arcmed.2022.06.005
|
86 |
Qiufeng Du, Yunlan Jiang, Yaxin Liu. Prevalence of metabolic syndrome in patients with end-stage renal disease: a systematic review and meta-analysis. International Urology and Nephrology 2023; 56(3): 1057 doi: 10.1007/s11255-023-03790-z
|
87 |
Wilson Bowlby, Leila R. Zelnick, Connor Henry, Jonathan Himmelfarb, Steven E. Kahn, Bryan Kestenbaum, Cassianne Robinson-Cohen, Kristina M. Utzschneider, Ian H. de Boer. Physical activity and metabolic health in chronic kidney disease: a cross-sectional study. BMC Nephrology 2016; 17(1) doi: 10.1186/s12882-016-0400-x
|
88 |
Suyuan Peng, Yadan Fan, Liwei Wang, Andrew Wen, Xusheng Liu, Hongfang Liu, Feichen Shen. Leveraging Association Rule Mining to Detect Pathophysiological Mechanisms of Chronic Kidney Disease Complicated by Metabolic Syndrome. 2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2018; : 1302 doi: 10.1109/BIBM.2018.8621226
|
89 |
John Lee, J. Rick Turner. Raising the Bar in Renal Sympathetic Denervation Research and Reporting. The Journal of Clinical Hypertension 2016; 18(2): 89 doi: 10.1111/jch.12666
|
90 |
Roberto Coccurello, Cinzia Volonté. P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.00199
|
91 |
Xiaoyu Cai, Yao Yao, Fei Teng, Yangling Li, Linwen Wu, Wei Yan, Nengming Lin. The role of P2X7 receptor in infection and metabolism: Based on inflammation and immunity. International Immunopharmacology 2021; 101: 108297 doi: 10.1016/j.intimp.2021.108297
|
92 |
|
93 |
Jullyana S.S. Quintans, Saravanan Shanmugam, Luana Heimfarth, Adriano Antunes S. Araújo, Jackson R.G.da S. Almeida, Laurent Picot, Lucindo J. Quintans-Júnior. Monoterpenes modulating cytokines - A review. Food and Chemical Toxicology 2019; 123: 233 doi: 10.1016/j.fct.2018.10.058
|
94 |
Ryuichi Kawamoto, Asuka Kikuchi, Taichi Akase, Daisuke Ninomiya, Yoshihisa Kasai, Nobuyuki Ohtsuka, Teru Kumagi. Increased body mass index above the upper normal limit is significantly associated with renal dysfunction among community-dwelling persons. International Urology and Nephrology 2020; 52(8): 1533 doi: 10.1007/s11255-020-02501-2
|
95 |
Sanne van der Rijt, Jaklien C. Leemans, Sandrine Florquin, Riekelt H. Houtkooper, Alessandra Tammaro. Immunometabolic rewiring of tubular epithelial cells in kidney disease. Nature Reviews Nephrology 2022; 18(9): 588 doi: 10.1038/s41581-022-00592-x
|
96 |
Tamara Tovar Sanchez, Mireille Mpoudi-Etame, Charles Kouanfack, Eric Delaporte, Alexandra Calmy, Francois Venter, Simiso Sokhela, Bronwyn Bosch, Godspower Akpomiemie, Angela Tembo, Toby Pepperrell, Bryony Simmons, Carmen Perez Casas, Kaitlyn McCann, Manya Mirchandani, Andrew Hill. Risks of metabolic syndrome in the ADVANCE and NAMSAL trials. Frontiers in Reproductive Health 2023; 5 doi: 10.3389/frph.2023.1133556
|
97 |
MikhailA Filippov, OlgaG Tatarnikova, NataliaV Pozdnyakova, VasilyV Vorobyov. Inflammation/bioenergetics-associated neurodegenerative pathologies and concomitant diseases: a role of mitochondria targeted catalase and xanthophylls. Neural Regeneration Research 2021; 16(2): 223 doi: 10.4103/1673-5374.290878
|
98 |
Isabel T.N. Nguyen, Jaap A. Joles, Marianne C. Verhaar, Hildo J. Lamb, Ilona A. Dekkers. Visceral and Ectopic Fat. 2023; : 243 doi: 10.1016/B978-0-12-822186-0.00006-7
|
99 |
Alice S. Ryan. Effects of Exercise on Hypertension. Molecular and Translational Medicine 2015; : 257 doi: 10.1007/978-3-319-17076-3_12
|
100 |
Soo Kyoung Kim, Ji Cheol Bae, Jong-Ha Baek, Kyu Yeon Hur, Moon-Kyu Lee, Jae Hyeon Kim. Is decreased lung function associated with chronic kidney disease? A retrospective cohort study in Korea. BMJ Open 2018; 8(4): e018928 doi: 10.1136/bmjopen-2017-018928
|
101 |
Riley C C Brown, Dev K Jegatheesan, Marguerite M Conley, Hannah L Mayr, Jaimon T Kelly, Lindsey Webb, Amandine Barnett, Heidi M Staudacher, Nicola W Burton, Nicole M Isbel, Graeme A Macdonald, Katrina L Campbell, Jeff S Coombes, Shelley E Keating, Ingrid J Hickman. Utilizing Technology for Diet and Exercise Change in Complex Chronic Conditions Across Diverse Environments (U-DECIDE): Protocol for a Randomized Controlled Trial. JMIR Research Protocols 2022; 11(7): e37556 doi: 10.2196/37556
|
102 |
Philip Kam‐Tao Li, Jack Kit‐Chung Ng, Yuk Lun Cheng, Tze Hoi Kwan, Chi Bon Leung, Miu Fong Lau, Koon Shing Choi, Samuel Ka‐Shun Fung, Yiu Wing Ho, Siu Ka Mak, Sydney Chi‐Wai Tang, Kin Shing Wong, David Yong, Sing Leung Lui. Relatives in silent kidney disease screening (RISKS) study: A Chinese cohort study. Nephrology 2017; 22(S4): 35 doi: 10.1111/nep.13148
|
103 |
Francesco Baratta, Laura D’Erasmo, Alessia Di Costanzo, Ilaria Umbro, Daniele Pastori, Francesco Angelico, Maria Del Ben. Metabolic Syndrome but Not Fatty Liver-Associated Genetic Variants Correlates with Glomerular Renal Function Decline in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines 2022; 10(3): 720 doi: 10.3390/biomedicines10030720
|
104 |
Isabelle C. V. S. Martins, Michel G. Maciel, José L. M. do Nascimento, Denise Mafra, Alexsandro F. Santos, Camila S. Padilha. Anthocyanins-rich interventions on oxidative stress, inflammation and lipid profile in patients undergoing hemodialysis: meta-analysis and meta-regression. European Journal of Clinical Nutrition 2023; 77(3): 316 doi: 10.1038/s41430-022-01175-6
|
105 |
Chang Hee Jung, Min Jung Lee, Yu Mi Kang, Jenie Y. Hwang, Eun Hee Kim, Joong-Yeol Park, Hong-Kyu Kim, Woo Je Lee. The risk of chronic kidney disease in a metabolically healthy obese population. Kidney International 2015; 88(4): 843 doi: 10.1038/ki.2015.183
|
106 |
Yajuan Qi, Xiaoqin Guo, Shaodong Guo. Metabolic Syndrome. 2015; : 1 doi: 10.1007/978-3-319-12125-3_28-2
|
107 |
Qingrong Pan, Yuan Xu, Ning Yang, Xia Gao, Jia Liu, Wenying Yang, Guang Wang. Comparison of Acarbose and Metformin on Albumin Excretion in Patients With Newly Diagnosed Type 2 Diabetes. Medicine 2016; 95(14): e3247 doi: 10.1097/MD.0000000000003247
|
108 |
Salwa Almomen, Qiunong Guan, Peihe Liang, Kaidi Yang, Ahmad Sidiqi, Adeera Levin, Caigan Du. Daily Intake of Grape Powder Prevents the Progression of Kidney Disease in Obese Type 2 Diabetic ZSF1 Rats. Nutrients 2017; 9(4): 345 doi: 10.3390/nu9040345
|
109 |
Mohammed Suhail Tazeem, Nirmala Devi Chandrasekaran, Niveda Srivatsa. Assessing the Utility of the Metabolic Score for Insulin Resistance (METS-IR) in Evaluating Metabolic Risk Among Individuals Undergoing Master Health Checkups in a Tertiary Care Hospital in South India: A Retrospective Cohort Study. Cureus 2024; doi: 10.7759/cureus.70289
|
110 |
Jae Hyun Jung, Gwan Gyu Song, Jong Dae Ji, Young Ho Lee, Jae-Hoon Kim, Young Ho Seo, Sung Jae Choi. Metabolic syndrome: prevalence and risk factors in Korean gout patients. The Korean Journal of Internal Medicine 2018; 33(4): 815 doi: 10.3904/kjim.2016.062
|
111 |
Yi Wang, Bin Sun, Li-Ting Sheng, Xiong-Fei Pan, Yanfeng Zhou, Jiang Zhu, Xiulou Li, Kun Yang, Kunquan Guo, Xiaomin Zhang, Meian He, Handong Yang, Tangchun Wu, An Pan. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese. Nutrition, Metabolism and Cardiovascular Diseases 2020; 30(11): 2017 doi: 10.1016/j.numecd.2020.06.025
|
112 |
Nasser M. Al-Daghri, Omar S. Al-Attas, Kaiser Wani, Shaun Sabico, Majed S. Alokail. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-12085-0
|
113 |
Arnaud Delautre, François Chantrel, Yves Dimitrov, Alexandre Klein, Olivier Imhoff, Clotilde Muller, Nicole Schauder, Thierry Hannedouche, Thierry Krummel. Metabolic syndrome in haemodialysis patients: prevalence, determinants and association to cardiovascular outcomes. BMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-02004-3
|
114 |
Titilola Falasinnu, Michelle M. O'Shaughnessy, Megan L. Troxell, Vivek Charu, Michael H. Weisman, Julia F. Simard. A review of non-immune mediated kidney disease in systemic lupus erythematosus: A hypothetical model of putative risk factors. Seminars in Arthritis and Rheumatism 2020; 50(3): 463 doi: 10.1016/j.semarthrit.2019.10.006
|